Imperious Pharmaceutical Private Limited
About Imperious Pharmaceutical Private Limited
Data last updated:
Imperious Pharmaceutical Private Limited is a private limited company based in Thane, Maharashtra, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 05 December 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U74999MH2018PTC317887. Its GSTIN is 22AAFCI0894Q1Z4 (Chhattisgarh).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors including Kiran Agrawal and Archana Kumari.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 509 Kastrui Maritri Vatikaparsik Nagar Kharegaon, Thane, Maharashtra, India – 400602.
As per the financials filed for FY 2025, the company reported a revenue of ₹91.9 Lakh, a growth of 2% compared to the previous year. For the same year it recorded a net profit of ₹40,229 (net margin 0.4%) and EBITDA of ₹1.57 Lakh (EBITDA margin 1.7%). Revenue has declined at a compounded annual rate (CAGR) of 5% over three years and 3% over five years.
As per MCA filings, the company has open charges of ₹10 Lakh on record.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered Address509 Kastrui Maritri Vatikaparsik Nagar Kharegaon, Thane, Maharashtra, India – 400602
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Imperious Pharmaceutical Private Limited
The main business activity of Imperious Pharmaceutical is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale trade, except of motor vehicles and motorcycles.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 46 | Wholesale trade, except of motor vehicles and motorcycles | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Imperious Pharmaceutical Private Limited FY 2025 filings available
Imperious Pharmaceutical Private Limited reported revenue of ₹91.9 Lakh (up 2% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Imperious Pharmaceutical Private Limited
Revenue rose 2% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 3%. EBITDA fell 26% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Imperious Pharmaceutical Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹1.57 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹40,229 | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Imperious Pharmaceutical Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 1.7% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 0.4% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Imperious Pharmaceutical are in the company report.
Financial statements from FY 2019
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Imperious Pharmaceutical Private Limited
Imperious Pharmaceutical Private Limited is compared with the companies closest to it by revenue in the same principal business activity (Wholesale trade, except of motor vehicles and motorcycles). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Green Fleet Private Limited | ₹92.11 Lakh (FY 2025) | •••• | •••• | 257.0% | •••• | Indore, Madhya Pradesh, India |
| Fairobuy E Commerce Private Limited | ₹92.03 Lakh (FY 2025) | •••• | •••• | •••• | Kozhikode, Kerala, India | |
| Gupta Fabrics Private Limited | ₹92.01 Lakh (FY 2025) | •••• | •••• | -40.0% | •••• | New Delhi, Delhi, India |
| Senfina Growth Private Limited | ₹91.97 Lakh (FY 2025) | •••• | •••• | 346.0% | •••• | Domjur, West Bengal, India |
| Betamed Exim Private Limited | ₹91.91 Lakh (FY 2024) | •••• | •••• | -8.0% | •••• | New Delhi, Delhi, India |
| Imperious Pharmaceutical Private Limited this company | ₹91.9 Lakh (FY 2025) | •••• | •••• | 2.0% | •••• | Thane, Maharashtra, India |
| Cudos Lifesciences Private Limited | ₹91.88 Lakh (FY 2024) | •••• | •••• | -30.0% | •••• | Pune, Maharashtra, India |
| Techsapphire Infra Consultants Private Limited | ₹91.86 Lakh (FY 2024) | •••• | •••• | -63.0% | •••• | Delhi, India |
| Medcuris Healthcare Private Limited | ₹91.78 Lakh (FY 2025) | •••• | •••• | 52.0% | •••• | New Delhi, Delhi, India |
| Bitech Electrovision India Private Limited | ₹91.77 Lakh (FY 2025) | •••• | •••• | 47.0% | •••• | Faridabad, Haryana, India |
| Jai Balaji Power Projects & Engg Private Limited | ₹91.69 Lakh (FY 2025) | •••• | •••• | 122.0% | •••• | Kolkata, West Bengal, India |
Peers are the five companies nearest above and the five nearest below Imperious Pharmaceutical by revenue in the same principal business activity (Wholesale trade, except of motor vehicles and motorcycles), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Board of Directors of Imperious Pharmaceutical Private Limited
Imperious Pharmaceutical has 3 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Kiran Agrawal Also directs: Xanadu Lifestyle Private Limited, RCK Multitrade Private Limited | Director | 05 Dec 2018 | 7 Years 10 Months | Current |
| Archana Kumari | Director | 05 Dec 2018 | 7 Years 10 Months | Current |
| Shraddhanjali Panda | Director | 05 Dec 2018 | 7 Years 10 Months | Current |
Ownership and Shareholding of Imperious Pharmaceutical Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Imperious Pharmaceutical Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 17 Apr 2025 | Others | ₹10 Lakh | Open |
Total charge records: 1 View all charges
Employees and EPFO Compliance at Imperious Pharmaceutical Private Limited
Employment history and EPFO contributions of people linked to Imperious Pharmaceutical.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Imperious Pharmaceutical Private Limited
Imperious Pharmaceutical Private Limited has 3 board changes on record since 2018: 3 appointments. The latest: Archana Kumari was appointed as Director on 05 Dec 2018.
Credit Ratings, Litigation & Regulatory Alerts for Imperious Pharmaceutical Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Imperious Pharmaceutical Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Imperious Pharmaceutical Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Imperious Pharmaceutical Private Limited
Imperious Pharmaceutical has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 22AAFCI0894Q1Z4 | Chhattisgarh | Active | 22 Jan 2019 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Imperious Pharmaceutical Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Imperious Pharmaceutical Private Limited
Imperious Pharmaceutical is an active private limited company based in Thane, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 05 December 2018 (8+ years old) and is registered under CIN U74999MH2018PTC317887.
Imperious Pharmaceutical reported revenue of ₹91.9 Lakh for FY 2025 (up 2% YoY).
Imperious Pharmaceutical has 3 current directors:
- Kiran Agrawal - Director
- Archana Kumari - Director
- Shraddhanjali Panda - Director
Imperious Pharmaceutical reported a net profit of ₹40,229 (net margin 0.4%) and EBITDA of ₹1.57 Lakh (EBITDA margin 1.7%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Imperious Pharmaceutical is -5% over three years and -3% over five years. In the latest year (FY 2025) revenue rose 2%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Imperious Pharmaceutical is 22AAFCI0894Q1Z4, registered in Chhattisgarh.
The CIN (Corporate Identification Number) of Imperious Pharmaceutical is U74999MH2018PTC317887. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Imperious Pharmaceutical was incorporated on 05 December 2018, making it 8+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Imperious Pharmaceutical by revenue are Green Fleet Private Limited, Fairobuy E Commerce Private Limited, Gupta Fabrics Private Limited, Senfina Growth Private Limited, Betamed Exim Private Limited and 5 more, all in the same principal business activity (Wholesale trade, except of motor vehicles and motorcycles).
Archana Kumari was appointed as Director on 05 Dec 2018. Kiran Agrawal was appointed as Director on 05 Dec 2018. Shraddhanjali Panda was appointed as Director on 05 Dec 2018.
The registered office of Imperious Pharmaceutical is at 509 Kastrui Maritri Vatikaparsik Nagar Kharegaon, Thane, Maharashtra, India – 400602.